NasdaqGM - Nasdaq Real Time Price USD

Lyra Therapeutics, Inc. (LYRA)

Compare
0.2211 +0.0147 (+7.12%)
As of 11:52:52 AM EST. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,471.0000
1,558.0000
1,363.0000
285.0000
--
Operating Expense
68,915.0000
67,086.0000
56,353.0000
43,900.0000
22,209.0000
Operating Income
-67,444.0000
-65,528.0000
-54,990.0000
-43,615.0000
-22,209.0000
Net Non Operating Interest Income Expense
3,855.0000
4,499.0000
1,041.0000
102.0000
82.0000
Other Income Expense
-33,973.0000
-1,592.0000
-1,316.0000
--
--
Pretax Income
-97,562.0000
-62,621.0000
-55,265.0000
-43,513.0000
-22,127.0000
Tax Provision
50.0000
59.0000
13.0000
--
--
Net Income Common Stockholders
-97,612.0000
-62,680.0000
-55,278.0000
-43,513.0000
-22,242.0000
Diluted NI Available to Com Stockholders
-97,612.0000
-62,680.0000
-55,278.0000
-43,513.0000
-22,242.0000
Basic EPS
-1.49
-1.26
-1.83
-3.35
-2.59
Diluted EPS
-1.49
-1.26
-1.83
-3.35
-2.59
Basic Average Shares
64,119.2150
49,804.2830
30,235.6890
12,986.1010
8,590.2050
Diluted Average Shares
64,119.2150
49,804.2830
30,235.6890
12,986.1010
8,590.2050
Total Operating Income as Reported
-101,417.0000
-67,120.0000
-56,306.0000
-43,615.0000
-22,209.0000
Total Expenses
68,915.0000
67,086.0000
56,353.0000
43,900.0000
22,209.0000
Net Income from Continuing & Discontinued Operation
-97,612.0000
-62,680.0000
-55,278.0000
-43,513.0000
-22,127.0000
Normalized Income
-70,773.3300
-61,422.3200
-54,238.3600
-43,513.0000
-22,127.0000
Interest Income
3,855.0000
4,499.0000
1,041.0000
102.0000
82.0000
Net Interest Income
3,855.0000
4,499.0000
1,041.0000
102.0000
82.0000
EBIT
-67,444.0000
-65,528.0000
-54,990.0000
-43,615.0000
-22,209.0000
EBITDA
-67,039.0000
-65,250.0000
-53,923.0000
-42,614.0000
-22,114.0000
Reconciled Depreciation
405.0000
278.0000
1,067.0000
1,001.0000
95.0000
Net Income from Continuing Operation Net Minority Interest
-97,612.0000
-62,680.0000
-55,278.0000
-43,513.0000
-22,127.0000
Total Unusual Items Excluding Goodwill
-33,973.0000
-1,592.0000
-1,316.0000
--
--
Total Unusual Items
-33,973.0000
-1,592.0000
-1,316.0000
--
--
Normalized EBITDA
-33,066.0000
-63,658.0000
-52,607.0000
-42,614.0000
-22,114.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
--
--
Tax Effect of Unusual Items
-7,134.3300
-334.3200
-276.3600
--
--
12/31/2020 - 5/1/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HLVX HilleVax, Inc.
2.1200
+2.42%
 
EPIX ESSA Pharma Inc.
1.8320
+2.35%
 
CLRB Cellectar Biosciences, Inc.
0.3227
+7.93%
 
ACHL Achilles Therapeutics plc
1.1400
0.00%
 
ADTX Aditxt, Inc.
0.2000
+5.37%
 
IKNA Ikena Oncology, Inc.
1.6100
-1.83%
 
SPRO Spero Therapeutics, Inc.
1.0700
+3.88%
 
BOLT Bolt Biotherapeutics, Inc.
0.5500
+2.78%
 
CDT Conduit Pharmaceuticals Inc.
0.0719
+4.81%
 
CNSP CNS Pharmaceuticals, Inc.
0.1207
+0.25%